The aim was to determine the feasibility of using the Amplatzer septal occluder for closure of
moderate and large secundum atrial septal defects in adults. Fifty patients aged 16–76 years …

Percutaneous transvenous closure of atrial septal defects (ASDs) has become feasible in
recent years, as later‐generation devices have largely overcome initial difficulties in device …

Little is known about the efficacy and safety of the 40 mm Amplatzer septal occluder (ASO).
Thirty‐three patients (22 female, 11 male) with a large secundum atrial septal defect (ASD) …

Aim: To evaluate the safety and efficacy of transcatheter closure of secundum atrial septal
defects (ASD) with the Amplatzer septal occluder. Methods: 236 consecutive patients with a …

Transcatheter closure of atrial septal defects (ASDs) was performed mainly in children and
adolescents. Information about outcome and complications in adults was limited. From …

The Amplatzer septal occluder (ASO) is used for transcatheter closure of atrial septal defects
(ASDs). This study aimed to determine the factors influencing successful closure with the …

Amplatzer septal occluder (AGA Med. Co., USA) is a novel device for occlusion of atrial
septal defect. We present our experience of transcatheter closure of atrial septal defects …

Transcatheter closure of secundum atrial septal defect (ASD) using clamshell or buttoned
devices is accompanied by a high incidence of residual shunt. Recently, a new self …

OBJECTIVE To assess the efficacy and complications of device occlusion of atrial septal
defects in adults, using the Amplatzer septal occluder (ASO). DESIGN A prospective …

Objectives We evaluated short-term results of transcatheter closure of secundum atrial
septal defects (ASD) with the Amplatzer septal occluder (ASO) in adults. Study design The …